Stephanie Carrington | IR, Westwicke |
Keith Kendall | President and Chief Executive Officer |
John Maxwell | SVP and Chief Financial Officer |
Dan Barber | SVP and Chief Operating Officer |
Ken Marshall | SVP and Chief Commercial Officer |
Gary Nachman | BMO Capital Markets |
Andreas Argyrides | Wedbush |
Thomas Flaten | Lake Street Capital |
Ladies and gentlemen, thank you for standing by, and welcome to the Q3 2020 Aquestive Therapeutics Inc. earnings conference call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator instructions] Please be advised, that today’s conference is being recorded.